https://www.selleckchem.com/products/eht-1864.html
Exertional dyspnea is common in cancer patients and limits their function. The impact of high-flow nasal cannula (HFNC) on exertional dyspnea in non-hypoxemic patients is unclear. In this double-blind, parallel-group, randomized trial, we assessed the effect of flow rate (high vs. low) and gas (oxygen vs. air) on exertional dyspnea in non-hypoxemic cancer patients. Cancer patients with oxygen saturation 90% at rest and exertion completed incremental and constant work (80% maximal) cycle ergometry while breathing low-flow air at 2 L
Like
Comment
Share
